Is there a future for ductal lavage?

Clinical Cancer Research

Volumn 13, Issue 16, 2007, Pages 4655-4656

  Fabian, Carol J ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ASPIRATION BIOPSY; BREAST CANCER; BREAST DUCT; BREAST HYPERPLASIA; CANCER RISK; CANCER SCREENING; CELL STRUCTURE; CHEMOPROPHYLAXIS; COST EFFECTIVENESS ANALYSIS; DUCTAL LAVAGE; EDITORIAL; EPITHELIUM CELL; HUMAN; INTERMETHOD COMPARISON; LAVAGE; MORPHOLOGY; NIPPLE ASPIRATE FLUID HARVEST; PERIAREOLAR FINE NEEDLE ASPIRATION; POSTMENOPAUSE; PREDICTION; PRIORITY JOURNAL;

BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; IRRIGATION;

EID: 34548100246     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-1056     Document Type: Editorial

References (23)

1. Wrensch MR, Petrakis NL, Miike R, et al. Breast cancer risk in women with abnormal cytology in nipple aspirates of beast fluid. J Natl Cancer Inst 2001;93:1791-8.
2. Fabian CJ, Kimler BF, Zalles CM, et al. Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst 2000;92:1217-27.
3. Tice JA, Miike R, Adduci K, Petrakis NL, King E, Wrensch MR. Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population. Cancer Epidemiol Biomarkers Prev 2005;14:324-8.
4. Mayo MS, Kimler BF, Fabian CJ. Evaluation of models for the prediction of breast cancer development in women at high risk of breast cancer. J Applied Res 2001;1:37-44.
5. Dooley WC, Ljung BM, Veronesi U, et al. Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst 2001;93:1624-32.
6. Francescatti DS, Kluskens L, Shah L. Ductal lavage using medically aseptic technique in women at high risk for breast cancer. Clin Breast Cancer 2004;5:299-302.
7. Khan SA, Baird C, Staradub VL, Morrow M. Ductal lavage and ductoscopy: the opportunities and the limitations. Clin Breast Cancer 2002;3:185-91.
8. Love SM, King BL. Ductal lavage in nipple aspirate fluid producing and non-producing ducts in healthy volunteers [abstract 5019]. Breast Cancer Res Treat 2004;88:S189-90.
9. Kurian AW, Mills MA, Jaffee M, et al. Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:1082-9.
10. Cazzaniga M, Severi G, Casadio C, Chiapparini L, Veronesi U, Decensi A. Atypia and Ki-67 expression from ductal lavage inwomen at different risk for breast cancer. Cancer Epidemiol Biomarkers Prev 2006;15:1311-5.
11. Mitchell G, Antill YC, Murray W, et al. Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation. Breast Cancer Res 2005;7:R1122-31.
12. Khan SA, Wiley EL, Rodriguez N, et al. Ductal lavage findings in women with known breast cancer undergoing mastectomy. J Natl Cancer Inst 2004;96:1510-8.
13. Going JJ, Moffat DF. Escaping from Flatland: clinical and biological aspects of human mammary duct anatomy in three dimensions. J Pathol 2004;203:538-44.
14. Arun B, Valero V, Logan C, et al. Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials. Clin Cancer Res 2007;13:4943-8.
15. Johnson-Maddux A, Ashfaq R, Cler L, et al. Reproducibility of cytologic atypia in repeat nipple duct lavage. Cancer 2005;103:1129-36.
16. Sharma P, Klemp JR, Simensen M, et al. Failure of high risk women to produce nipple aspirate fluid does not exclude detection of cytologic atypia in random periareolar fine needle aspiration specimens. Breast Cancer Res Treat 2004;87:59-64.
17. Zalles CM, Kimler BF, Simonsen M, Clark JL, Metheny T, Fabian CJ. Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer. Breast Cancer Res Treat 2006;97:191-7.
18. Fabian CJ, Kimler BF, Mayo MS, Khan SA. Breast-tissue sampling for risk assessment and prevention. Endocr Relat Cancer 2005;12:185-213.
19. Fabian CJ, Kimler BF, Brady DA, et al. A phase II breast cancer chemoprevention trial of oral α-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers. Clin Cancer Res 2002;8:3105-17.
20. Ozanne EM, Esserman LJ. Evaluation of breast cancer risk assessment techniques: a cost-effectiveness analysis. Cancer Epidemiol Biomarkers Prev 2004;13:2043-52.
21. Sauter ER, Wagner-Mann C, Ehya H, Klein-Szanto A. Biologic markers of breast cancer in nipple aspirate fluid and nipple discharge are associated with clinical findings. Cancer Detect Prev 2007;31:50-8.
22. Khan QJ, Kimler BF, Clark J, Metheny T, Zalles CM, Fabian CJ. Ki-67 Expression in benign breast ductal cells obtained by random periareolar fine needle aspiration. Cancer Epidemiol Biomarkers Prev 2005;14:786-9.
23. Fackler MJ, Malone K, Zhang Z, et al. Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin Cancer Res 2006;12:3306-10.